RWE: Unleashing the information of real world data
Real World evidence is taking utmost importance in nowadays healthcare. Using patient-level data allows to better understand treatment practice, treatment patterns, compliance, safety, long-term outcomes, and comparisons going beyond the RCT data. It is of critical interest for regulators, payers and the pharmaceutical industry (R&D, medical affairs, market access, and safety. Business & Decision Life Sciences positions itself as a key partner in providing integrated services. Our services include trainings, business question formulation, data landscaping, high-end computing and dynamic / real time deliverables in line with the most recent technological, methodological and regulatory standards.
Epidemiology: Beyond incidence and prevalence
Modern Epidemiology and pharmacoepidemiology are the cornerstones of healthcare research. Our offer goes way behind incidences and prevalences and include healthcare use, unmet needs, morbidity, mortality and health economics. Business & Decision Life Sciences offers access to virtually any existing data on diseases, treatments, their treatments and their potential side effects. We also collaborate with major data providers to generate innovative quality solutions when information is scarce.
Health Economics: Determining the value of innovation in healthcare
Health Economics have evolved considerably over time. Business & Decision Life Sciences combines a network of experts in this field and state-of-the-art technology allowing for accurate modelling of any healthcare intervention. Our offer includes Markov and Monte-Carlo simulations, impact models, budget optimization, outcome-based pricing, multi criteria decision analysis, support to HTA and pricing & reimbursement submissions as well as corresponding trainings.